© Copyright 2026 American Medical Association. All rights reserved.
The actin smooth muscle antibody (ASMA) test, identified by CPT® Code 86015, is a laboratory test that plays a crucial role in the evaluation of various liver conditions. This test is particularly significant in assessing whether liver inflammation is of autoimmune origin. Autoantibodies, such as ASMAs, target specific structural proteins found in smooth muscle, with a notable impact on liver tissues. The presence of these antibodies in the bloodstream, especially at a titer greater than 1:40, suggests a high probability of autoimmune hepatitis or liver damage stemming from autoimmune processes. However, it is important to note that ASMAs can also be associated with other medical conditions, including infectious mononucleosis, melanoma, and certain cancers like breast or ovarian cancer. In cases where ASMAs are not detected, it indicates that the liver symptoms may be attributed to non-autoimmune causes. The ASMA test is performed on a venous blood sample, which is analyzed using immunoassay techniques, commonly the enzyme-linked immunosorbent assay (ELISA). This code is applicable for each actin smooth muscle antibody tested and is not specific to any particular testing method. Additionally, the ASMA test can assist in differentiating between autoimmune hepatitis and systemic lupus erythematosus. It is often conducted alongside other tests, such as antinuclear antibody tests, to provide a comprehensive evaluation for diagnosing autoimmune hepatitis.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.